BIO-TECHNE CORP (TECH) Stock Fundamental Analysis

USA Nasdaq NASDAQ:TECH • US09073M1045

66.78 USD
+0.92 (+1.4%)
At close: Feb 6, 2026
67.3 USD
+0.52 (+0.78%)
After Hours: 2/6/2026, 8:08:08 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to TECH. TECH was compared to 57 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making TECH a very profitable company, without any liquidiy or solvency issues. While showing a medium growth rate, TECH is valued expensive at the moment. These ratings would make TECH suitable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year TECH was profitable.
  • TECH had a positive operating cash flow in the past year.
  • In the past 5 years TECH has always been profitable.
  • TECH had a positive operating cash flow in each of the past 5 years.
TECH Yearly Net Income VS EBIT VS OCF VS FCFTECH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • TECH's Return On Assets of 3.04% is fine compared to the rest of the industry. TECH outperforms 73.68% of its industry peers.
  • The Return On Equity of TECH (3.91%) is better than 73.68% of its industry peers.
  • TECH has a better Return On Invested Capital (9.33%) than 84.21% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for TECH is below the industry average of 13.80%.
  • The last Return On Invested Capital (9.33%) for TECH is above the 3 year average (9.00%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.04%
ROE 3.91%
ROIC 9.33%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
TECH Yearly ROA, ROE, ROICTECH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With a decent Profit Margin value of 6.32%, TECH is doing good in the industry, outperforming 73.68% of the companies in the same industry.
  • TECH's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 22.13%, TECH belongs to the top of the industry, outperforming 91.23% of the companies in the same industry.
  • TECH's Operating Margin has been stable in the last couple of years.
  • Looking at the Gross Margin, with a value of 66.83%, TECH belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
  • TECH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.13%
PM (TTM) 6.32%
GM 66.83%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
TECH Yearly Profit, Operating, Gross MarginsTECH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

7

2. Health

2.1 Basic Checks

  • TECH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • TECH has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for TECH has been increased compared to 5 years ago.
  • The debt/assets ratio for TECH is higher compared to a year ago.
TECH Yearly Shares OutstandingTECH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
TECH Yearly Total Debt VS Total AssetsTECH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • TECH has an Altman-Z score of 12.64. This indicates that TECH is financially healthy and has little risk of bankruptcy at the moment.
  • TECH's Altman-Z score of 12.64 is amongst the best of the industry. TECH outperforms 98.25% of its industry peers.
  • The Debt to FCF ratio of TECH is 1.34, which is an excellent value as it means it would take TECH, only 1.34 years of fcf income to pay off all of its debts.
  • TECH has a Debt to FCF ratio of 1.34. This is amongst the best in the industry. TECH outperforms 89.47% of its industry peers.
  • A Debt/Equity ratio of 0.15 indicates that TECH is not too dependend on debt financing.
  • TECH has a Debt to Equity ratio (0.15) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.34
Altman-Z 12.64
ROIC/WACC0.85
WACC10.93%
TECH Yearly LT Debt VS Equity VS FCFTECH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • TECH has a Current Ratio of 4.22. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
  • TECH's Current ratio of 4.22 is fine compared to the rest of the industry. TECH outperforms 66.67% of its industry peers.
  • A Quick Ratio of 2.81 indicates that TECH has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.81, TECH is in line with its industry, outperforming 57.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.22
Quick Ratio 2.81
TECH Yearly Current Assets VS Current LiabilitesTECH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 8.84% over the past year.
  • TECH shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.25% yearly.
  • TECH shows a small growth in Revenue. In the last year, the Revenue has grown by 5.23%.
  • The Revenue has been growing by 10.55% on average over the past years. This is quite good.
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
Revenue 1Y (TTM)5.23%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.61% on average over the next years. This is quite good.
  • Based on estimates for the next years, TECH will show a small growth in Revenue. The Revenue will grow by 7.10% on average per year.
EPS Next Y4.66%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
EPS Next 5Y8.61%
Revenue Next Year0.56%
Revenue Next 2Y3.68%
Revenue Next 3Y5.76%
Revenue Next 5Y7.1%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TECH Yearly Revenue VS EstimatesTECH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
TECH Yearly EPS VS EstimatesTECH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 33.90, the valuation of TECH can be described as expensive.
  • TECH's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.92. TECH is valued slightly more expensive when compared to this.
  • The Price/Forward Earnings ratio is 29.74, which means the current valuation is very expensive for TECH.
  • Based on the Price/Forward Earnings ratio, TECH is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 27.78. TECH is around the same levels.
Industry RankSector Rank
PE 33.9
Fwd PE 29.74
TECH Price Earnings VS Forward Price EarningsTECH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • TECH's Enterprise Value to EBITDA is on the same level as the industry average.
  • TECH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TECH is cheaper than 63.16% of the companies in the same industry.
Industry RankSector Rank
P/FCF 46.44
EV/EBITDA 27.75
TECH Per share dataTECH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • TECH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)7.28
PEG (5Y)3.01
EPS Next 2Y7.87%
EPS Next 3Y10.61%

4

5. Dividend

5.1 Amount

  • TECH has a yearly dividend return of 0.47%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.09, TECH pays a better dividend. On top of this TECH pays more dividend than 92.98% of the companies listed in the same industry.
  • With a Dividend Yield of 0.47, TECH pays less dividend than the S&P500 average, which is at 1.83.
Industry RankSector Rank
Dividend Yield 0.47%

5.2 History

  • The dividend of TECH has a limited annual growth rate of 0.11%.
  • TECH has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of TECH decreased recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
TECH Yearly Dividends per shareTECH Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

  • 65.26% of the earnings are spent on dividend by TECH. This is not a sustainable payout ratio.
  • TECH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP65.26%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
TECH Yearly Income VS Free CF VS DividendTECH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
TECH Dividend Payout.TECH Dividend Payout, showing the Payout Ratio.TECH Dividend Payout.PayoutRetained Earnings

BIO-TECHNE CORP

NASDAQ:TECH (2/6/2026, 8:08:08 PM)

After market: 67.3 +0.52 (+0.78%)

66.78

+0.92 (+1.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners107.49%
Inst Owner Change-0.69%
Ins Owners0.25%
Ins Owner Change2.3%
Market Cap10.40B
Revenue(TTM)1.22B
Net Income(TTM)76.84M
Analysts81.74
Price Target71.44 (6.98%)
Short Float %6.67%
Short Ratio5.3
Dividend
Industry RankSector Rank
Dividend Yield 0.47%
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP65.26%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.05%
Min EPS beat(2)-2.04%
Max EPS beat(2)4.14%
EPS beat(4)3
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)5
Avg EPS beat(8)2.5%
EPS beat(12)5
Avg EPS beat(12)-1.36%
EPS beat(16)7
Avg EPS beat(16)-2.4%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-1.54%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)1.28%
Revenue beat(8)3
Avg Revenue beat(8)-1.11%
Revenue beat(12)3
Avg Revenue beat(12)-2.41%
Revenue beat(16)4
Avg Revenue beat(16)-2.23%
PT rev (1m)0.26%
PT rev (3m)6.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.17%
EPS NY rev (1m)-0.1%
EPS NY rev (3m)-1.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.34%
Valuation
Industry RankSector Rank
PE 33.9
Fwd PE 29.74
P/S 8.55
P/FCF 46.44
P/OCF 41.41
P/B 5.29
P/tB 16.34
EV/EBITDA 27.75
EPS(TTM)1.97
EY2.95%
EPS(NY)2.25
Fwd EY3.36%
FCF(TTM)1.44
FCFY2.15%
OCF(TTM)1.61
OCFY2.41%
SpS7.81
BVpS12.62
TBVpS4.09
PEG (NY)7.28
PEG (5Y)3.01
Graham Number23.65
Profitability
Industry RankSector Rank
ROA 3.04%
ROE 3.91%
ROCE 11.3%
ROIC 9.33%
ROICexc 9.93%
ROICexgc 24.48%
OM 22.13%
PM (TTM) 6.32%
GM 66.83%
FCFM 18.41%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.34
Debt/EBITDA 0.8
Cap/Depr 25.63%
Cap/Sales 2.24%
Interest Coverage 14.5
Cash Conversion 66.94%
Profit Quality 291.58%
Current Ratio 4.22
Quick Ratio 2.81
Altman-Z 12.64
F-Score5
WACC10.93%
ROIC/WACC0.85
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
EPS Next Y4.66%
EPS Next 2Y7.87%
EPS Next 3Y10.61%
EPS Next 5Y8.61%
Revenue 1Y (TTM)5.23%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
Revenue Next Year0.56%
Revenue Next 2Y3.68%
Revenue Next 3Y5.76%
Revenue Next 5Y7.1%
EBIT growth 1Y-10.6%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year15.61%
EBIT Next 3Y13.34%
EBIT Next 5Y8.56%
FCF growth 1Y3.97%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-2.5%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%

BIO-TECHNE CORP / TECH FAQ

Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?

ChartMill assigns a fundamental rating of 6 / 10 to TECH.


What is the valuation status of BIO-TECHNE CORP (TECH) stock?

ChartMill assigns a valuation rating of 3 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Overvalued.


How profitable is BIO-TECHNE CORP (TECH) stock?

BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.


What is the financial health of BIO-TECHNE CORP (TECH) stock?

The financial health rating of BIO-TECHNE CORP (TECH) is 7 / 10.


Is the dividend of BIO-TECHNE CORP sustainable?

The dividend rating of BIO-TECHNE CORP (TECH) is 4 / 10 and the dividend payout ratio is 65.26%.